| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.05 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.05 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.05 |
| mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.05 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |